Indolent course of the cutaneous Hodgkin's disease

Journal of Cutaneous Pathology

Volumn 32, Issue 2, 2005, Pages 176-178

  Jurišić, Vladimir ^a   Bogunović, Marina ^b   Čolovic, Nataša ^c   Čolović, Milica ^b,c,d  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b Clinical Center of   (Yugoslavia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

AGED; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; COMORBIDITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALIGNANT NEOPLASTIC DISEASE; PROGNOSIS; RARE DISEASE; SKIN DISEASE;

AGED; DIAGNOSIS, DIFFERENTIAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; SKIN NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 13444271729     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2005.00280.x     Document Type: Article

References (15)

1. Hayes TG, Rabin VR, Rosen T, Zubler MA. Hodgkin's disease presenting in the skin. Case report and review of the literature. J Am Acad Dermatol 1990; 22: 944.
2. Smith JL, Butler JJ. Skin involvement in Hodgkin's disease. Cancer 1980; 45: 354.
3. White RM, Patterson JW. Cutaneous involvement in Hodgkin's disease. Cancer 1985; 55: 1136.
4. Cavalli F. Rare syndromes in Hodgkin's disease. Ann Oncol 1998; 9: 109.
5. Gadzia J, Kestenbaun T. Granulomatous slack skin without evidence of a clonal T-cell proliferation. J Am Acad Dermatol 2004; 50: 4.
6. Van Hale HM, Winkelmann RK. Nodular lymphoid disease of the head and neck: lymphocytoma cutis, benign lymphocytic infiltrate of Jessner, and their distinction from malignant lymphoma. J Am Acad Dermatol 1985; 12: 455.
7. Ralfkiaer E, Lange Wantzin G, Mason DY, Stein H, Thomsen K. Characterization of benign cutaneous lymphocytic infiltrates by monoclonal antibodies. Br J Dermatol 1984; 111: 635.
8. van der Putte SC, Toonstra J, van Wichen DF, van Unnik JA, van Vloten WA. The expression of the Hodgkin's disease-associated antigen Ki-1 in cutaneous infiltrates. Acta Derm Venereol 1988; 68: 202.
9. Davies MJ, Phillips BJ, Rumsby PC. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C. Mutat Res 1993; 290: 145.
10. Siotos N, Kerl H, Murphy SB, Kadin ME. Primary cutaneous Hodgkin's disease: unique clinical, morphologic and immunophenotypic findings. Am J Dermatopathol 1994; 16: 2.
11. Moretti S, Pimpenelli N, Di Lollo S, Vallecchi C, Bosi A. In situ immunologic characterization of cutaneous involvement in Hodgkin's disease. Cancer 1989; 63: 661.
12. Shaw MT, Jacobs SR. Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection. Cancer 1989; 64: 2585.
13. Konjevic G, Jurisic V, Banicevic B, Spuzic I. Difference in NK cell activity between patients with non-Hodgkin's lymphoma and Hodgkin's disease. Br J Haematol 1999; 104: 144.
14. Cerroni L, Schmid CB, Kerl H. Cutaneous Hodgkin's disease: an immunohistochemical analysis. J Cutan Pathol 1995; 22: 229.
15. Kumar S, Kingma DW, Weiss WB, Raffeld M, Jaffe ES. Primary cutaneous Hodgkin's disease with evolution to systemic disease. Association with the Epstein-Barr virus. Am J Surg Pathol 1996; 20: 754.